Otero Jose Manuel 4/A

What Happened

• Jose Manuel Otero, Chief Operating Officer of Lexeo Therapeutics (LXEO), disposed of 721 shares on November 18, 2025 in an open-market sale to cover tax obligations tied to the release of restricted stock units (RSUs). The shares were sold at a weighted average price of $9.27 per share, for proceeds of approximately $6,684.

Key Details

• Transaction date: November 18, 2025 (amended filing submitted Feb 20, 2026).
• Sale type/code: S (sale to cover tax withholding on RSU release; footnote F2).
• Price: weighted average $9.27; execution prices ranged from $9.09 to $9.37 across multiple trades (footnote F3).
• Proceeds: ~$6,684.
• Ownership after transaction: Not specified in the provided details; filing notes holdings include 47,733 RSUs (footnote F4).
• Filing status: This is an amended Form 4. The original Form 4 filed Nov 20, 2025 incorrectly reported the sale date as Aug 18, 2025; this amendment corrects the date (footnote F1).
• The reporting person offers to provide a breakdown of the number of shares sold at each separate sale price upon request (footnote F3).

Context

• This was a routine tax-withholding sale tied to RSU vesting rather than an independent decision to reduce exposure; such sales are common and typically viewed as administrative rather than a direct signal of insider sentiment. The amendment corrects a prior reporting error about the transaction date.